Home › Funds › Nova R Wealth, Inc. › BME
Nova R Wealth, Inc. position in BME
BLACKROCK HEALTH SCIENCES OPPS INV A · Financials
Nova R Wealth, Inc. reported holding 133,657 shares of BME (BLACKROCK HEALTH SCIENCES OPPS INV A) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 1.77% of its reported portfolio and ranking #15 among its reported holdings. Nova R Wealth, Inc. has disclosed BME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Nova R Wealth, Inc.'s BME position evolved
Nova R Wealth, Inc. first disclosed a stake in BME in Q3 2023 at 400,376 shares (US$15.7M). Across 13 filings, Nova R Wealth, Inc. increased the stake 0 time(s), trimmed it 12 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 133,657 shares valued at US$5.9M — a reduction of -7,279 shares quarter over quarter.. Notable position changes include a 33% trim in Q1 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 400.38K | $15.67M | New |
| Q4 2023 | 377.77K | $15.28M | Reduce |
| Q1 2024 | 357.87K | $14.83M | Reduce |
| Q2 2024 | 339.83K | $13.88M | Reduce |
| Q3 2024 | 332.97K | $13.96M | Reduce |
| Q4 2024 | 320.24K | $12.15M | Reduce |
| Q1 2025 | 313.85K | $12.13M | Reduce |
| Q2 2025 | 281.35K | $10.26M | Reduce |
| Q3 2025 | 253.72K | $9.45M | Reduce |
| Q4 2025 | 230.69K | $9.49M | Reduce |
| Q1 2026 | 154.62K | $5.95M | Reduce |
| Q2 2026 | 140.94K | $6.05M | Reduce |
| Q3 2026 | 133.66K | $5.90M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BME and 13F data
BME (BLACKROCK HEALTH SCIENCES OPPS INV A) is a Financials company. 20 other funds we track also report a position in BME — the largest reported positions include 1607 Capital Partners, LLC (US$7.0M), Cypress Capital Management LLC (WY) (US$2.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BME
- 1607 Capital Partners, LLC 163.55K sh · $7.02M · Q2 2026
- Cypress Capital Management LLC (WY) 51.86K sh · $2.29M · Q3 2026
More on Nova R Wealth, Inc.
FAQ
How long has Nova R Wealth, Inc. held BME?
Nova R Wealth, Inc. has disclosed BME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Nova R Wealth, Inc.'s current position in BME?
As of Q3 2026, Nova R Wealth, Inc. holds 133.66K shares of BME (BLACKROCK HEALTH SCIENCES OPPS INV A), valued at $5.90M, representing 1.77% of its reported portfolio and ranking #15.
Has Nova R Wealth, Inc. been buying or selling BME?
In the latest 13F filing (Q3 2026), Nova R Wealth, Inc. reduced its position in BME.
Which other funds hold BME?
Other major institutional holders of BME include 1607 Capital Partners, LLC, Cypress Capital Management LLC (WY), among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.